CDEK
← All organizations

Alumis Inc

For profit

Also known as: Alumis Inc

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Mar 17, 2022

Last known activity

May 9, 2025

Timeline

2020s

  1. May 1, 2025

    ACELYRIN Inc.— Acquired

Drugs by trial phase (5 distinct, 16 trials)

Phase 3 (2 own, 1 via acquisition)

Phase 2 (0 own, 1 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (14)

Details

Founded
San Francisco, CA, US
Last known activity
May 9, 2025